首页> 外文会议>International Congress on Coronary Artery Disease >18-Month Outcome After Percutaneous Intervention in Post-Coronary Artery Bypass Graft Patients
【24h】

18-Month Outcome After Percutaneous Intervention in Post-Coronary Artery Bypass Graft Patients

机译:在冠状动脉后旁路接枝患者中经皮干预后18个月的结果

获取原文

摘要

From January-05 to September-06, 91 patients with previous history of bypass surgery have undergone percutaneous intervention at our institution. Patients were clinically followed until July-07, recording the incidence of major adverse cardiac events (MACE). 58% patients were treated in the native arteries, 34% in the grafts, and 8% in both. A total of 154 lesions were treated with 197 stents (84% drug-eluting stents). Procedural success rate was 95,6%. Mean follow-up was 18+-7 months. Out of hospital MACE incidence was 18,6%: death occurred in 4.4% of the patients, myocardial infarction in 2.2%, and 12% underwent repeat revascularization (target lesion revascularization in 5,4%). Multivariate analysis revealed left ventricular ejection fraction <50% and multivessel intervention to be independent predictors of MACE at follow-up.
机译:从1月05日至9月6日起,91例旁路手术历史历史历史都经历了在我们的机构的经济干预。临床上患者直至7月-07,记录了主要不良心脏事件(MACE)的发病率。 58%的患者在本地动脉中治疗,嫁接中的34%,两者均为8%。共有154个病变用197个支架(84%的药物洗脱支架)治疗。程序成功率为95,6%。平均随访18±7个月。出于医院佩怀发病率为18,6%:4.4%的患者发生死亡,心肌梗死2.2%,12%的重复血运重建(目标病变血运重建于5,4%)。多变量分析显示左心室喷射分数<50%和多血管干预,以便在随访中成为术的术语独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号